This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hagensee, M E Articles by Galloway, D A Search for Related Content PubMed PubMed Citation Articles by Hagensee, M E Articles by Galloway, D A

Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins.

Fred Hutchinson Cancer Research Center, Seattle, Washington 98104-2092.

ABSTRACT

Vaccinia virus vectors were used to express the major (L1) and minor (L2) capsid proteins of human papillomavirus type 1 (HPV-1) with the vaccinia virus early (p7.5K) or late (pSynth, p11K) promoters. All constructs expressed the appropriate-sized HPV proteins, and both L1 and L2, singly or in combination, localized to the nucleus. Capsids were purified by cesium chloride density gradient centrifugation from nuclei of cells infected with a vaccinia virus-L1 (vac-L1) recombinant or a vac-L1-L2 recombinant but not from vac-L2-infected cells. Electron microscopy showed that the particles were 55 nm in diameter and had icosahedral symmetry. Immunogold-labeled antibodies confirmed the presence of the L1 and L2 proteins in the HPV-1 capsids. Capsids containing L1 alone were fewer and more variable in size and shape than capsids containing the L1 and L2 proteins. The L1-plus-L2 capsids were indistinguishable in appearance from HPV-1 virions obtained from plantar warts. The ability to produce HPV capsids in vitro will be useful in many studies of HPV pathogenicity.

This article has been cited by other articles:

• Buck, C. B., Cheng, N., Thompson, C. D., Lowy, D. R., Steven, A. C., Schiller, J. T., Trus, B. L. (2008). Arrangement of L2 within the Papillomavirus Capsid. J. Virol. 82: 5190-5197 [Abstract] [Full Text]  
• Thones, N., Herreiner, A., Schadlich, L., Piuko, K., Muller, M. (2008). A Direct Comparison of Human Papillomavirus Type 16 L1 Particles Reveals a Lower Immunogenicity of Capsomeres than Viruslike Particles with Respect to the Induced Antibody Response. J. Virol. 82: 5472-5485 [Abstract] [Full Text]  
• Rizk, R. Z., Christensen, N. D., Michael, K. M., Muller, M., Sehr, P., Waterboer, T., Pawlita, M. (2008). Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types. J. Gen. Virol. 89: 117-129 [Abstract] [Full Text]  
• Bishop, B., Dasgupta, J., Klein, M., Garcea, R. L., Christensen, N. D., Zhao, R., Chen, X. S. (2007). Crystal Structures of Four Types of Human Papillomavirus L1 Capsid Proteins: UNDERSTANDING THE SPECIFICITY OF NEUTRALIZING MONOCLONAL ANTIBODIES. J. Biol. Chem. 282: 31803-31811 [Abstract] [Full Text]  
• Chan, J. K., Berek, J. S. (2007). Impact of the Human Papilloma Vaccine on Cervical Cancer. JCO 25: 2975-2982 [Abstract] [Full Text]  
• Schmiedeskamp, M. R, Kockler, D. R (2006). Human Papillomavirus Vaccines. The Annals of Pharmacotherapy 40: 1344-1352 [Abstract] [Full Text]  
• Pichichero, M. E. (2006). Prevention of cervical cancer through vaccination of adolescents.. CLIN PEDIATR 45: 393-398  
• Carter, J. J., Wipf, G. C., Madeleine, M. M., Schwartz, S. M., Koutsky, L. A., Galloway, D. A. (2006). Identification of human papillomavirus type 16 l1 surface loops required for neutralization by human sera.. J. Virol. 80: 4664-4672 [Abstract] [Full Text]  
• Orozco, J. J., Carter, J. J., Koutsky, L. A., Galloway, D. A. (2005). Humoral Immune Response Recognizes a Complex Set of Epitopes on Human Papillomavirus Type 6 L1 Capsomers. J. Virol. 79: 9503-9514 [Abstract] [Full Text]  
• Patterson, N. A., Smith, J. L., Ozbun, M. A. (2005). Human Papillomavirus Type 31b Infection of Human Keratinocytes Does Not Require Heparan Sulfate. J. Virol. 79: 6838-6847 [Abstract] [Full Text]  
• Bousarghin, L., Hubert, P., Franzen, E., Jacobs, N., Boniver, J., Delvenne, P. (2005). Human papillomavirus 16 virus-like particles use heparan sulfates to bind dendritic cells and colocalize with langerin in Langerhans cells. J. Gen. Virol. 86: 1297-1305 [Abstract] [Full Text]  
• Buck, C. B., Thompson, C. D., Pang, Y.-Y. S., Lowy, D. R., Schiller, J. T. (2005). Maturation of Papillomavirus Capsids. J. Virol. 79: 2839-2846 [Abstract] [Full Text]  
• Longworth, M. S., Laimins, L. A. (2004). The Binding of Histone Deacetylases and the Integrity of Zinc Finger-Like Motifs of the E7 Protein Are Essential for the Life Cycle of Human Papillomavirus Type 31. J. Virol. 78: 3533-3541 [Abstract] [Full Text]  
• Becker, K. A., Florin, L., Sapp, C., Maul, G. G., Sapp, M. (2004). Nuclear Localization but Not PML Protein Is Required for Incorporation of the Papillomavirus Minor Capsid Protein L2 into Virus-Like Particles. J. Virol. 78: 1121-1128 [Abstract] [Full Text]  
• Selinka, H.-C., Giroglou, T., Nowak, T., Christensen, N. D., Sapp, M. (2003). Further Evidence that Papillomavirus Capsids Exist in Two Distinct Conformations. J. Virol. 77: 12961-12967 [Abstract] [Full Text]  
• Carter, J. J., Wipf, G. C., Benki, S. F., Christensen, N. D., Galloway, D. A. (2003). Identification of a Human Papillomavirus Type 16-Specific Epitope on the C-Terminal Arm of the Major Capsid Protein L1. J. Virol. 77: 11625-11632 [Abstract] [Full Text]  
• Carter, J. J., Madeleine, M. M., Wipf, G. C., Garcea, R. L., Pipkin, P. A., Minor, P. D., Galloway, D. A. (2003). Lack of Serologic Evidence for Prevalent Simian Virus 40 Infection in Humans. JNCI J Natl Cancer Inst 95: 1522-1530 [Abstract] [Full Text]  
• Devaraj, K., Gillison, M. L., Wu, T.-C. (2003). DEVELOPMENT OF HPV VACCINES FOR HPV-ASSOCIATED HEAD AND NECK SQUAMOUS CELL CARCINOMA. Crit. Rev. Oral Biol. Med. 14: 345-362 [Abstract] [Full Text]  
• Biemelt, S., Sonnewald, U., Galmbacher, P., Willmitzer, L., Muller, M. (2003). Production of Human Papillomavirus Type 16 Virus-Like Particles in Transgenic Plants. J. Virol. 77: 9211-9220 [Abstract] [Full Text]  
• Rosenblatt, K. A., Carter, J. J., Iwasaki, L. M., Galloway, D. A., Stanford, J. L. (2003). Serologic Evidence of Human Papillomavirus 16 and 18 Infections and Risk of Prostate Cancer. Cancer Epidemiol. Biomarkers Prev. 12: 763-768 [Abstract] [Full Text]  
• Studentsov, Y. Y., Ho, G. Y. F., Marks, M. A., Bierman, R., Burk, R. D. (2003). Polymer-Based Enzyme-Linked Immunosorbent Assay Using Human Papillomavirus Type 16 (HPV16) Virus-Like Particles Detects HPV16 Clade-Specific Serologic Responses. J. Clin. Microbiol. 41: 2827-2834 [Abstract] [Full Text]  
• Cameron, J. E., Snowhite, I. V., Chaturvedi, A. K., Hagensee, M. E. (2003). Human Papillomavirus-Specific Antibody Status in Oral Fluids Modestly Reflects Serum Status in Human Immunodeficiency Virus-Positive Individuals. CVI 10: 431-438 [Abstract] [Full Text]  
• Finnen, R. L., Erickson, K. D., Chen, X. S., Garcea, R. L. (2003). Interactions between Papillomavirus L1 and L2 Capsid Proteins. J. Virol. 77: 4818-4826 [Abstract] [Full Text]  
• Opalka, D., Lachman, C. E., MacMullen, S. A., Jansen, K. U., Smith, J. F., Chirmule, N., Esser, M. T. (2003). Simultaneous Quantitation of Antibodies to Neutralizing Epitopes on Virus-Like Particles for Human Papillomavirus Types 6, 11, 16, and 18 by a Multiplexed Luminex Assay. CVI 10: 108-115 [Abstract] [Full Text]  
• Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., Jansen, K. U., the Proof of Principle Study Investigators, (2002). A Controlled Trial of a Human Papillomavirus Type 16 Vaccine. NEJM 347: 1645-1651 [Abstract] [Full Text]  
• Emeny, R. T., Wheeler, C. M., Jansen, K. U., Hunt, W. C., Fu, T.-M., Smith, J. F., MacMullen, S., Esser, M. T., Paliard, X. (2002). Priming of Human Papillomavirus Type 11-Specific Humoral and Cellular Immune Responses in College-Aged Women with a Virus-Like Particle Vaccine. J. Virol. 76: 7832-7842 [Abstract] [Full Text]  
• Studentsov, Y. Y., Schiffman, M., Strickler, H. D., Ho, G. Y. F., Pang, Y.-Y. S., Schiller, J., Herrero, R., Burk, R. D. (2002). Enhanced Enzyme-Linked Immunosorbent Assay for Detection of Antibodies to Virus-Like Particles of Human Papillomavirus. J. Clin. Microbiol. 40: 1755-1760 [Abstract] [Full Text]  
• Bousarghin, L., Combita-Rojas, A.-L., Touze, A., El Mehdaoui, S., Sizaret, P.-Y., Bravo, M.-M., Coursaget, P. (2002). Detection of Neutralizing Antibodies against Human Papillomaviruses (HPV) by Inhibition of Gene Transfer Mediated by HPV Pseudovirions. J. Clin. Microbiol. 40: 926-932 [Abstract] [Full Text]  
• Yuan, H., Estes, P. A., Chen, Y., Newsome, J., Olcese, V. A., Garcea, R. L., Schlegel, R. (2001). Immunization with a Pentameric L1 Fusion Protein Protects against Papillomavirus Infection. J. Virol. 75: 7848-7853 [Abstract] [Full Text]  
• Fligge, C., Schafer, F., Selinka, H.-C., Sapp, C., Sapp, M. (2001). DNA-Induced Structural Changes in the Papillomavirus Capsid. J. Virol. 75: 7727-7731 [Abstract] [Full Text]  
• Gerber, S., Lane, C., Brown, D. M., Lord, E., DiLorenzo, M., Clements, J. D., Rybicki, E., Williamson, A.-L., Rose, R. C. (2001). Human Papillomavirus Virus-Like Particles Are Efficient Oral Immunogens when Coadministered with Escherichia coli Heat-Labile Enterotoxin Mutant R192G or CpG DNA. J. Virol. 75: 4752-4760 [Abstract] [Full Text]  
• Kawana, Y., Kawana, K., Yoshikawa, H., Taketani, Y., Yoshiike, K., Kanda, T. (2001). Human Papillomavirus Type 16 Minor Capsid Protein L2 N-Terminal Region Containing a Common Neutralization Epitope Binds to the Cell Surface and Enters the Cytoplasm. J. Virol. 75: 2331-2336 [Abstract] [Full Text]  
• Nardelli-Haefliger, D., Roden, R., Balmelli, C., Potts, A., Schiller, J., De Grandi, P. (1999). Mucosal but Not Parenteral Immunization with Purified Human Papillomavirus Type 16 Virus-Like Particles Induces Neutralizing Titers of Antibodies throughout the Estrous Cycle of Mice. J. Virol. 73: 9609-9613 [Abstract] [Full Text]  
• HAGENSEE, M. E., SLAVINSKY, J. III, GAFFGA, C. M., SUROS, J., KISSINGER, P., MARTIN, D. H. (1999). Seroprevalence of Human Papillomavirus Type 16 in Pregnant Women. Obstet Gynecol 94: 653-658 [Abstract] [Full Text]  
• Marais,, D., Passmore,, J.-A., Maclean,, J., Rose, R., Williamson, A.-L. (1999). A recombinant human papillomavirus (HPV) type 16 L1-vaccinia virus murine challenge model demonstrates cell-mediated immunity against HPV virus-like particles. J. Gen. Virol. 80: 2471-2475 [Abstract] [Full Text]  
• Zhou, J., Liu, W. J., Peng, S. W., Sun, X. Y., Frazer, I. (1999). Papillomavirus Capsid Protein Expression Level Depends on the Match between Codon Usage and tRNA Availability. J. Virol. 73: 4972-4982 [Abstract] [Full Text]  
• Joyce, J. G., Tung, J.-S., Przysiecki, C. T., Cook, J. C., Lehman, E. D., Sands, J. A., Jansen, K. U., Keller, P. M. (1999). The L1 Major Capsid Protein of Human Papillomavirus Type 11 Recombinant Virus-like Particles Interacts with Heparin and Cell-surface Glycosaminoglycans on Human Keratinocytes. J. Biol. Chem. 274: 5810-5822 [Abstract] [Full Text]  
• Balmelli, C., Roden, R., Potts, A., Schiller, J., De Grandi, P., Nardelli-Haefliger, D. (1998). Nasal Immunization of Mice with Human Papillomavirus Type 16 Virus-Like Particles Elicits Neutralizing Antibodies in Mucosal Secretions. J. Virol. 72: 8220-8229 [Abstract] [Full Text]  
• Touze, A., El Mehdaoui, S., Sizaret, P.-Y., Mougin, C., Muñoz, N., Coursaget, P. (1998). The L1 Major Capsid Protein of Human Papillomavirus Type 16 Variants Affects Yield of Virus-Like Particles Produced in an Insect Cell Expression System. J. Clin. Microbiol. 36: 2046-2051 [Abstract] [Full Text]  
• Rose, R. C., White, W. I., Li, M., Suzich, J. A., Lane, C., Garcea, R. L. (1998). Human Papillomavirus Type 11 Recombinant L1 Capsomeres Induce Virus-Neutralizing Antibodies. J. Virol. 72: 6151-6154 [Abstract] [Full Text]  
• Sapp, M., Fligge, C., Petzak, I., Harris, J. R., Streeck, R. E. (1998). Papillomavirus Assembly Requires Trimerization of the Major Capsid Protein by Disulfides between Two Highly Conserved Cysteines. J. Virol. 72: 6186-6189 [Abstract] [Full Text]  
• Lowy, D. R., Schiller, J. T. (1998). Papillomaviruses and Cervical Cancer: Pathogenesis and Vaccine Development. J Natl Cancer Inst Monogr 1998: 27-30 [Abstract] [Full Text]  
• White, W. I., Wilson, S. D., Bonnez, W., Rose, R. C., Koenig, S., Suzich, J. A. (1998). In Vitro Infection and Type-Restricted Antibody-Mediated Neutralization of Authentic Human Papillomavirus Type 16. J. Virol. 72: 959-964 [Abstract] [Full Text]  
• McCarthy, M. P., White, W. I., Palmer-Hill, F., Koenig, S., Suzich, J. A. (1998). Quantitative Disassembly and Reassembly of Human Papillomavirus Type 11 Viruslike Particles In Vitro. J. Virol. 72: 32-41 [Abstract] [Full Text]  
• Day, P. M., Roden, R. B. S., Lowy, D. R., Schiller, J. T. (1998). The Papillomavirus Minor Capsid Protein, L2, Induces Localization of the Major Capsid Protein, L1, and the Viral Transcription/Replication Protein, E2, to PML Oncogenic Domains. J. Virol. 72: 142-150 [Abstract] [Full Text]